Magellan Bioanalytics
Magellan Bioanalytics, founded in 2018, develops advanced AI and machine learning software tools for mass spectrometry data analysis, enabling comprehensive, rapid, and flexible comparative expression analysis across complex biomolecular samples. Their flagship product, COMPASS, supports biotech, pharma, and healthcare research by extracting detailed differential expression information from mass spec datasets, facilitating larger studies and accelerating discovery. The company also offers bespoke data analysis services, custom software applications, and a proprietary OMICS data archive to enhance research capabilities and data accessibility. Magellan Bioanalytics is positioned as a technology innovator in proteomics software, combining expertise in biology and computer science to address bottlenecks in mass spec data analysis and empower ambitious research projects.
Magellan Bioanalytics
Magellan Bioanalytics, founded in 2018, develops advanced AI and machine learning software tools for mass spectrometry data analysis, enabling comprehensive, rapid, and flexible comparative expression analysis across complex biomolecular samples. Their flagship product, COMPASS, supports biotech, pharma, and healthcare research by extracting detailed differential expression information from mass spec datasets, facilitating larger studies and accelerating discovery. The company also offers bespoke data analysis services, custom software applications, and a proprietary OMICS data archive to enhance research capabilities and data accessibility. Magellan Bioanalytics is positioned as a technology innovator in proteomics software, combining expertise in biology and computer science to address bottlenecks in mass spec data analysis and empower ambitious research projects.